<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url>
<loc>https://ro.prisysbiotech.com/</loc>
<image:image>
<image:title>Non  -  Uman  Primat  Cercetare  Platformă  &amp;  CRO | PRISYS  Biotehnologie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/logo.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/</loc>
<image:image>
<image:title>Farmacologie NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/</loc>
<image:image>
<image:title>Cercetarea traducerilor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/</loc>
<image:image>
<image:title>PK PD ADME</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/</loc>
<image:image>
<image:title>Evaluarea siguranței</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/biosafety-research/</loc>
<image:image>
<image:title>Cercetare de biosecuritate</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/non-human-primate.html</loc>
<image:image>
<image:title>Non-Human Primate (NHP)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
<image:image>
<image:title>Non-Human Primate (NHP)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html</loc>
<image:image>
<image:title>New And Modified Applications</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png</image:loc>
</image:image>
<image:image>
<image:title>New And Modified Applications</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html</loc>
<image:image>
<image:title>Single-dose &amp; Repeated Dose Toxicity Testing</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg</image:loc>
</image:image>
<image:image>
<image:title>Single-dose &amp; Repeated Dose Toxicity Testing</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/toxicokinetics.html</loc>
<image:image>
<image:title>Toxicokinetics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png</image:loc>
</image:image>
<image:image>
<image:title>Toxicokinetics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html</loc>
<image:image>
<image:title>The NHP Pharmacology Of Prisys</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg</image:loc>
</image:image>
<image:image>
<image:title>The NHP Pharmacology Of Prisys</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html</loc>
<image:image>
<image:title>What Is A NHP Study</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg</image:loc>
</image:image>
<image:image>
<image:title>What Is A NHP Study</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html</loc>
<image:image>
<image:title>Dose Range Finding Test</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png</image:loc>
</image:image>
<image:image>
<image:title>Dose Range Finding Test</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/biosafety-research/biosafetyresearch.html</loc>
<image:image>
<image:title>Biosafety Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg</image:loc>
</image:image>
<image:image>
<image:title>Biosafety Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Uveitis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png</image:loc>
</image:image>
<image:image>
<image:title>Uveitis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html</loc>
<image:image>
<image:title>Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg</image:loc>
</image:image>
<image:image>
<image:title>Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/nhpresources.html</loc>
<image:image>
<image:title>NHP Resources</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Resources</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Psoriasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg</image:loc>
</image:image>
<image:image>
<image:title>Psoriasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html</loc>
<image:image>
<image:title>NHP Lung Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Lung Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Hemophilia A Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg</image:loc>
</image:image>
<image:image>
<image:title>Hemophilia A Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Glaucoma Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png</image:loc>
</image:image>
<image:image>
<image:title>Glaucoma Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html</loc>
<image:image>
<image:title>NHP Non-Alcoholic Steatohepatitis (NASH) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Non-Alcoholic Steatohepatitis (NASH) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html</loc>
<image:image>
<image:title>NHP Asthma/atopic Dermatitis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Asthma/atopic Dermatitis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html</loc>
<image:image>
<image:title>Myopia Hyperopia Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png</image:loc>
</image:image>
<image:image>
<image:title>Myopia Hyperopia Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html</loc>
<image:image>
<image:title>Rheumatoid Arthritis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg</image:loc>
</image:image>
<image:image>
<image:title>Rheumatoid Arthritis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>NHP Acute Myocardial Infarction (AMI) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Acute Myocardial Infarction (AMI) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html</loc>
<image:image>
<image:title>Inflammatory Bowel Disease Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png</image:loc>
</image:image>
<image:image>
<image:title>Inflammatory Bowel Disease Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>AMD Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png</image:loc>
</image:image>
<image:image>
<image:title>AMD Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html</loc>
<image:image>
<image:title>Pharmacokinetics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png</image:loc>
</image:image>
<image:image>
<image:title>Pharmacokinetics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/translational-studies.html</loc>
<image:image>
<image:title>Translational Studies</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png</image:loc>
</image:image>
<image:image>
<image:title>Translational Studies</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg</image:loc>
</image:image>
<image:image>
<image:title>T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html</loc>
<image:image>
<image:title>Pharmacodynamics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pharmacodynamics</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html</loc>
<image:image>
<image:title>Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg</image:loc>
</image:image>
<image:image>
<image:title>Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html</loc>
<image:image>
<image:title>Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png</image:loc>
</image:image>
<image:image>
<image:title>Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html</loc>
<image:image>
<image:title>NHP Chronic Obstructive Pulmonary Disease (COPD) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Chronic Obstructive Pulmonary Disease (COPD) Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html</loc>
<image:image>
<image:title>Epilepsy Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg</image:loc>
</image:image>
<image:image>
<image:title>Epilepsy Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html</loc>
<image:image>
<image:title>Multiple Sclerosis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg</image:loc>
</image:image>
<image:image>
<image:title>Multiple Sclerosis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html</loc>
<image:image>
<image:title>Neuropathic Pain Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png</image:loc>
</image:image>
<image:image>
<image:title>Neuropathic Pain Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/toxicology.html</loc>
<image:image>
<image:title>Toxicology</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg</image:loc>
</image:image>
<image:image>
<image:title>Toxicology</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html</loc>
<image:image>
<image:title>Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke &amp; Brain Ischemia</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg</image:loc>
</image:image>
<image:image>
<image:title>Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke &amp; Brain Ischemia</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/safety-evaluation/immunotoxicity.html</loc>
<image:image>
<image:title>Immunotoxicity Testing and NHP Drug Safety Evaluation</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg</image:loc>
</image:image>
<image:image>
<image:title>Immunotoxicity Testing and NHP Drug Safety Evaluation</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html</loc>
<image:image>
<image:title>NHP(monkey) Disease Models</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png</image:loc>
</image:image>
<image:image>
<image:title>NHP(monkey) Disease Models</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/adme.html</loc>
<image:image>
<image:title>ADME</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/adme55f5d.jpg</image:loc>
</image:image>
<image:image>
<image:title>ADME</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/adme55f5d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html</loc>
<image:image>
<image:title>Coagulation/Hemostasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg</image:loc>
</image:image>
<image:image>
<image:title>Coagulation/Hemostasis Nonhuman Primates Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html</loc>
<image:image>
<image:title>AI-based NHP Behavior Analysis System</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png</image:loc>
</image:image>
<image:image>
<image:title>AI-based NHP Behavior Analysis System</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html</loc>
<image:image>
<image:title>ClearPoint Navigation For CNS Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg</image:loc>
</image:image>
<image:image>
<image:title>ClearPoint Navigation For CNS Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html</loc>
<image:image>
<image:title>Parkinson&#39;s Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg</image:loc>
</image:image>
<image:image>
<image:title>Parkinson&#39;s Disease Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/clinical-imaging.html</loc>
<image:image>
<image:title>Imagistica clinică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Imagistica clinică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg</image:loc>
</image:image>
<image:image>
<image:title>Clinical Imaging</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html</loc>
<image:image>
<image:title>Immunosuppression Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg</image:loc>
</image:image>
<image:image>
<image:title>Immunosuppression Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html</loc>
<image:image>
<image:title>Hyperlipoidemia Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png</image:loc>
</image:image>
<image:image>
<image:title>Hyperlipoidemia Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html</loc>
<image:image>
<image:title>A-V Shunt Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg</image:loc>
</image:image>
<image:image>
<image:title>A-V Shunt Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html</loc>
<image:image>
<image:title>Endometriosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png</image:loc>
</image:image>
<image:image>
<image:title>Endometriosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html</loc>
<image:image>
<image:title>Modelul diabetului zaharat de tip 2</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png</image:loc>
</image:image>
<image:image>
<image:title>Modelul diabetului zaharat de tip 2</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html</loc>
<image:image>
<image:title>Renal Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg</image:loc>
</image:image>
<image:image>
<image:title>Renal Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html</loc>
<image:image>
<image:title>Type 1 Diabetes Mellitus Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png</image:loc>
</image:image>
<image:image>
<image:title>Type 1 Diabetes Mellitus Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html</loc>
<image:image>
<image:title>Convection-Enhanced Delivery (CED) Technology</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png</image:loc>
</image:image>
<image:image>
<image:title>Convection-Enhanced Delivery (CED) Technology</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/clearpoint/nhp-neuroscience.html</loc>
<image:image>
<image:title>NHP Neuroscience</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Neuroscience</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html</loc>
<image:image>
<image:title>Atopic Dermatitis NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg</image:loc>
</image:image>
<image:image>
<image:title>Atopic Dermatitis NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html</loc>
<image:image>
<image:title>Pruritus NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg</image:loc>
</image:image>
<image:image>
<image:title>Pruritus NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html</loc>
<image:image>
<image:title>Targeted Organ Drug Delivery Platform in NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png</image:loc>
</image:image>
<image:image>
<image:title>Targeted Organ Drug Delivery Platform in NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html</loc>
<image:image>
<image:title>Inflammatory Bowel Disease IBD NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png</image:loc>
</image:image>
<image:image>
<image:title>Inflammatory Bowel Disease IBD NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html</loc>
<image:image>
<image:title>AAV-α-Synuclein Overexpression NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg</image:loc>
</image:image>
<image:image>
<image:title>AAV-α-Synuclein Overexpression NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html</loc>
<image:image>
<image:title>Heart Failure NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg</image:loc>
</image:image>
<image:image>
<image:title>Heart Failure NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html</loc>
<image:image>
<image:title>Acute Lung Inflammation (ALI) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png</image:loc>
</image:image>
<image:image>
<image:title>Acute Lung Inflammation (ALI) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html</loc>
<image:image>
<image:title>Nose-to-Brain Drug Delivery</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg</image:loc>
</image:image>
<image:image>
<image:title>Nose-to-Brain Drug Delivery</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html</loc>
<image:image>
<image:title>Acute Hemorrhagic Shock Model NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png</image:loc>
</image:image>
<image:image>
<image:title>Acute Hemorrhagic Shock Model NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html</loc>
<image:image>
<image:title>Retinitis Pigmentosa (RP) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png</image:loc>
</image:image>
<image:image>
<image:title>Retinitis Pigmentosa (RP) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html</loc>
<image:image>
<image:title>Liver Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png</image:loc>
</image:image>
<image:image>
<image:title>Liver Fibrosis Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html</loc>
<image:image>
<image:title>DSA-Guided Interventional Platform For NHP Research | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png</image:loc>
</image:image>
<image:image>
<image:title>DSA-Guided Interventional Platform For NHP Research | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html</loc>
<image:image>
<image:title>NHP Intrathecal (IT) Injection &amp; CSF Sampling Services | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Intrathecal (IT) Injection &amp; CSF Sampling Services | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/translation-research/biodistribution-imaging-service.html</loc>
<image:image>
<image:title>Biodistribution Imaging Service</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png</image:loc>
</image:image>
<image:image>
<image:title>Biodistribution Imaging Service</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html</loc>
<image:image>
<image:title>NHP Intracerebral (ICM) Injection| Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg</image:loc>
</image:image>
<image:image>
<image:title>NHP Intracerebral (ICM) Injection| Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html</loc>
<image:image>
<image:title>Focal Segmental Glomerulosclerosis (FSGS) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg</image:loc>
</image:image>
<image:image>
<image:title>Focal Segmental Glomerulosclerosis (FSGS) NHP Model</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html</loc>
<image:image>
<image:title>NHP Intracerebroventricular (ICV) Injection | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png</image:loc>
</image:image>
<image:image>
<image:title>NHP Intracerebroventricular (ICV) Injection | Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003172174701568.html</loc>
<image:image>
<image:title>Imagistica moleculară în modelele NHP pentru dezvoltarea de medicamente translaționale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969425800438784.html</loc>
<image:image>
<image:title>Webinar NHP BehaviorAtlas|Urmărirea comportamentală 3D NHP pentru dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724286673134592.html</loc>
<image:image>
<image:title>Recapitulare 2025: Cum Prisys redefinește fiabilitatea translațională în cercetarea NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17557593965421568.html</loc>
<image:image>
<image:title>NHP - Farmacologie și servicii farmacodinamice|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530304790504448.html</loc>
<image:image>
<image:title>Faceți cunoștință cu Biotehnologia Prisys la viitorul UE Roadshow: septembrie 2025</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451761556284416.html</loc>
<image:image>
<image:title>Prisys Biotech-2025 Revizuire la jumătatea anului</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244211878814720.html</loc>
<image:image>
<image:title>Faceți cunoștință cu Prisys în viitoarea Show-Roadshow în martie 2025</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84002191.html</loc>
<image:image>
<image:title>Raport anual PRISYS 2024: Avansarea modelelor NHP și a cercetării preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77696621.html</loc>
<image:image>
<image:title>Buletin informativ Prisys Biotech 2024 Q2 - R&amp;D preclinic îmbunătățit pentru terapie SNC cu modele PRISYS reactive încrucișate</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028065757651968.html</loc>
<image:image>
<image:title>De ce modelele animale reușesc sau eșuează în dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021152863609856.html</loc>
<image:image>
<image:title>Angajamentul țintă cantitativ PET în NHP-uri pentru medicamentele SNC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015311196251136.html</loc>
<image:image>
<image:title>De la video la date: urmărire 3D AI pentru comportamentul NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015410315174912.html</loc>
<image:image>
<image:title>Imagini de biodistribuție PET la primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003172435796992.html</loc>
<image:image>
<image:title>PBPK vs. Modele compartimentate: de ce contează PBPK</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993164133540864.html</loc>
<image:image>
<image:title>Recapitulare webinar: Avansarea cercetării translaționale NHP prin fenotiparea digitală comportamentală</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990411993539584.html</loc>
<image:image>
<image:title>Biomarkeri PK în dezvoltarea preclinice a medicamentelor|Expunere-Răspuns și PK/PD</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/behavior-in-rhesus-17985048237024256.html</loc>
<image:image>
<image:title>Comportament spontan de sine-vătămator la macaci Rhesus: un model translațional NHP pentru dezvoltarea medicamentelor neuropsihiatrice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985039499371520.html</loc>
<image:image>
<image:title>Modele de eficacitate MIDD și NHP în dezvoltarea translațională a medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17976601920119808.html</loc>
<image:image>
<image:title>AI-Analiza comportamentală 3D NHP|Fenotiparea comportamentală fără markeri</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/webinar-nhp-behavioratlas-17976602663199744.html</loc>
<image:image>
<image:title>Webinar global|Cuantificarea comportamentelor complexe NHP: introducerea NHP BehaviorAtlas pentru fenotiparea comportamentală 3D cu fidelitate înaltă-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969425802159104.html</loc>
<image:image>
<image:title>AI-Analiză comportamentală NHP pentru dezvoltarea preclinice de medicamente|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17976605786055680.html</loc>
<image:image>
<image:title>Când să introduceți studiile NHP în dezvoltarea medicamentelor autoimune</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17979412245734400.html</loc>
<image:image>
<image:title>Modele NHP IBD: Ce ne învață enterocolita cronică la macaci Rhesus despre inflamația intestinală translațională</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17976615058547712.html</loc>
<image:image>
<image:title>Livrarea AAV ghidată RMN-în modele cerebrale NHP pentru terapia genică a SNC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17976611168674816.html</loc>
<image:image>
<image:title>De ce contează medicamentele de control pozitiv în modelele de boli autoimune|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17976620758410240.html</loc>
<image:image>
<image:title>Screening ADA inițial la maimuțe spălate-pentru studii biologice preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969426015511552.html</loc>
<image:image>
<image:title>Mecanisme de durere: modelul UVB arsuri solare este un instrument de translație vital</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969426012496896.html</loc>
<image:image>
<image:title>Modele NHP ale dietei materne bogate în-grasimi și programării obezității în copilărie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946107855545344.html</loc>
<image:image>
<image:title>Interpretarea patologiei clinice la câini și primate non-umane în studii preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946108039455744.html</loc>
<image:image>
<image:title>Biomarkeri pentru imagistica moleculară: Avansarea cercetării translaționale și a dezvoltării medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946108097700864.html</loc>
<image:image>
<image:title>Ce este farmacocinetica neliniară? Mecanisme, caracteristici și implicații pentru dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946107933615104.html</loc>
<image:image>
<image:title>De ce imagistica moleculară NHP este esențială pentru studiile PET translaționale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946107995890688.html</loc>
<image:image>
<image:title>Ce este imagistica moleculară și de ce este importantă în dezvoltarea medicamentelor?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946089369510912.html</loc>
<image:image>
<image:title>NHP Radionuclide Biodistribution Studies: Molecular Imaging For Translational Drug Development</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-heart-failure-model-17946087494329344.html</loc>
<image:image>
<image:title>Modelul de insuficiență cardiacă NHP sprijină cercetarea translațională privind terapia genică de restaurare a telomerilor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946087066477568.html</loc>
<image:image>
<image:title>Cum DSA și CTA Imaging îmbunătățesc evaluarea siguranței medicamentelor cardiovasculare</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946086762832896.html</loc>
<image:image>
<image:title>Model de tromboză de șunt arteriovenos NHP la maimuțele Cynomolgus pentru evaluarea translațională a medicamentelor antitrombotice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888417132078080.html</loc>
<image:image>
<image:title>Date farmacocinetice ca biomarker translațional</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888417199170560.html</loc>
<image:image>
<image:title>Modele non-primate umane de fibroză pulmonară: creșterea preciziei translaționale în dezvoltarea medicamentelor respiratorii</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-models-translational-drug-development-17888417787864064.html</loc>
<image:image>
<image:title>De ce dezvoltarea medicamentelor depinde din ce în ce mai mult de modelele NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888417352295424.html</loc>
<image:image>
<image:title>Datele PK ca biomarker farmacodinamic: Avansarea dezvoltării translaționale a medicamentelor prin farmacologie cantitativă</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853633781605376.html</loc>
<image:image>
<image:title>Studii de farmacologie non-GLP pentru transmiterea reglementărilor: integritatea datelor și cerințele de laborator</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853633914151936.html</loc>
<image:image>
<image:title>Proiectarea strategică a studiilor farmacocinetice nonclinice: de la profilarea ADME la luarea deciziilor translaționale-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853633681236992.html</loc>
<image:image>
<image:title>NHP AV-Model de tromboză șunt pentru evaluarea siguranței medicamentelor|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853634107925504.html</loc>
<image:image>
<image:title>Ce este farmacocinetica neliniară? Mecanisme și evaluare translațională PK|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853633757668352.html</loc>
<image:image>
<image:title>Prisys Biotech sprijină aprobarea IND a UX-GIP001 de către FDA și CDE|Platforma de livrare a NHP CNS</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/157.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853633899291648.html</loc>
<image:image>
<image:title>Urmărirea celulelor imune in vivo și dezvoltarea trasoarelor PET în modelele NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853633903059968.html</loc>
<image:image>
<image:title>Imagistica PET cu transportor de dopamină în modelele NHP|Imagistica SNC|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853633698817024.html</loc>
<image:image>
<image:title>Biodistribuția PET/CT în modelele NHP pentru livrarea medicamentelor SNC|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853633743037440.html</loc>
<image:image>
<image:title>Platformă mare-de radioetichetare a animalelor și de imagistică in vivo pentru dezvoltarea translațională a medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853633675682816.html</loc>
<image:image>
<image:title>De ce dezvoltarea medicamentelor se bazează tot mai mult pe modelele NHP: rolul esențial al primatelor în medicina translațională|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853633728062464.html</loc>
<image:image>
<image:title>Provocări și soluții pentru dezvoltarea medicamentelor IPF|Modele NHP cu imagistică CT și PFT</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853633967039488.html</loc>
<image:image>
<image:title>Sistem AI Markerless NHP 3D de analiză a comportamentului pentru cercetarea preclinică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/evaluating-dmpk-properties-17853633815290880.html</loc>
<image:image>
<image:title>Evaluarea proprietăților DMPK ale compușilor candidați în descoperirea timpurie a medicamentelor|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853633804215296.html</loc>
<image:image>
<image:title>RMN-Livrarea SNC ghidată în modele NHP|Platformă translațională IMRI și CED</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853633894097920.html</loc>
<image:image>
<image:title>Studii de biodistribuție NHP CNS|Livrarea intratecală de ARN|PRISYS Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853633947689984.html</loc>
<image:image>
<image:title>Cadru translațional PK/PD: Maimuța Cynomolgus la predicția dozei umane|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724286829093888.html</loc>
<image:image>
<image:title>Când durerea devine o amintire: factorii emoționali ai durerii cronice și avantajul modelului NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724286638941184.html</loc>
<image:image>
<image:title>Multi-Evaluarea durerii: viitorul dezvoltării medicamentelor analgezice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724312359740416.html</loc>
<image:image>
<image:title>De ce atât de multe analgezice eșuează în studiile preclinice? Răspunsul constă în modul în care măsurăm durerea</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724312906130432.html</loc>
<image:image>
<image:title>Proiectarea punctului de timp pentru prelevarea de sânge în studiile farmacocinetice (PK)|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724286742324224.html</loc>
<image:image>
<image:title>Statistici PK: Parametrii analizei non-compartimentale (NCA) și aplicațiile preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724286695138304.html</loc>
<image:image>
<image:title>De ce modelele de primate non-umane sunt esențiale pentru terapia cu oligonucleotide SNC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724286713586688.html</loc>
<image:image>
<image:title>Metabolismul acidului uric la oameni vs maimuțe: implicații translaționale pentru dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724286679491584.html</loc>
<image:image>
<image:title>Model de fibroză hepatică asociată non-primatelor umane MASH-|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724286682932224.html</loc>
<image:image>
<image:title>De ce IMRI-livrarea de medicamente ghidată pe creier este esențială pentru o direcționare precisă în studiile NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674622661583872.html</loc>
<image:image>
<image:title>Sistem de analiză comportamentală NHP 3D fără markeri condus de AI-|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674622745633792.html</loc>
<image:image>
<image:title>LPS-Inflamația pulmonară acută indusă (ALI) Model NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674622765982720.html</loc>
<image:image>
<image:title>Modelul HDM+SEB-dermatită atopică indusă (AtD) la maimuțele Cynomolgus</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674614193513472.html</loc>
<image:image>
<image:title>Explicarea modelelor PK cu un- la multi-compartiment|Farmacocinetica NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674622962443264.html</loc>
<image:image>
<image:title>Cum să alegi un CRO preclinic de încredere|Criterii cheie pentru companiile de biotehnologie|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674622795883520.html</loc>
<image:image>
<image:title>Evaluare translațională CAR-T: expertiză in vitro și sprijin pentru studii NHP — Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674614022185984.html</loc>
<image:image>
<image:title>De ce mai mult de 90% dintre candidații la medicamente SNC eșuează în studiile clinice?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674614055511040.html</loc>
<image:image>
<image:title>Modele preclinice pentru boala Parkinson: un ghid pentru selectarea modelelor de neurotoxine, genetice și NHP|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674614111544320.html</loc>
<image:image>
<image:title>Livrare de înaltă{0}}precizie a medicamentelor și platforme de traducere NHP-conduse prin inteligență artificială</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625851266311168.html</loc>
<image:image>
<image:title>Th17-Driven NHP Imunologie Modele|Cercetare autoimună translațională la Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625851377509376.html</loc>
<image:image>
<image:title>Sistemul BehaviorAtlas® bazat pe AI-NHP|Platformă de analiză comportamentală 3D|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625851380638720.html</loc>
<image:image>
<image:title>Șablon RFP pentru studii NHP|Accelerați eficiența cercetării preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625851218928640.html</loc>
<image:image>
<image:title>Model de durere cu alodinie rece la maimuțele Cynomolgus|Prisys Biotehnologies</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625851433952256.html</loc>
<image:image>
<image:title>RMN-Platformă de livrare a medicamentelor intracerebrale ghidate|Prisys Biotech CNS Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625851530404864.html</loc>
<image:image>
<image:title>Modele de boli respiratorii NHP și platformă de livrare a medicamentelor pe căile respiratorii|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-renal-biopsy-17625851632067584.html</loc>
<image:image>
<image:title>Platformă de biopsie renală NHP și modele de boli de rinichi|Prisys Biotech</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/276.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625851495130112.html</loc>
<image:image>
<image:title>Studii PK și livrare direcționată de medicamente|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625851294999552.html</loc>
<image:image>
<image:title>Platforma de analiză comportamentală bazată pe-prisys Biotechnologies NHP Research și AI</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625851174528000.html</loc>
<image:image>
<image:title>Tehnologie de livrare naz-la-creier (N2B) pentru cercetarea SNC|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625851150590976.html</loc>
<image:image>
<image:title>SHR-2004: O descoperire în prevenirea TEV pentru pacienții cu cancer ovarian - O poveste de succes de Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538853234304000.html</loc>
<image:image>
<image:title>Modele de maimuță Cynomolgus și Rhesus|CRO preclinic Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530304761619456.html</loc>
<image:image>
<image:title>Fibroza pulmonară idiopatică (IPF) Model NHP|Prisys biotehnologic CRO</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530304738599936.html</loc>
<image:image>
<image:title>Studii de biodistribuție a maimuței Cynomolgus|CRO preclinic Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530304706028544.html</loc>
<image:image>
<image:title>Modele Prisys Biotech NHP pentru cercetarea hematologiei și a accidentului vascular cerebral</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-importance-of-administration-volume-17530304651240448.html</loc>
<image:image>
<image:title>Importanța volumului de administrare în studiile preclinice|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/brain-targeted-drug-delivery-17530304499360768.html</loc>
<image:image>
<image:title>Brain - Livrare de droguri vizată|Prisys Biotech Preclinical NHP Research</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530304751068160.html</loc>
<image:image>
<image:title>Dezvoltarea medicamentelor ADC|Cadru translațional PK/PD în studiile preclinice NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499189197693952.html</loc>
<image:image>
<image:title>Modele de durere NHP pentru descoperirea drogurilor translaționale|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499189019190272.html</loc>
<image:image>
<image:title>Ser vs. Plasma: Alegerea matricei optime pentru bioanaliza preclinica</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499189033772032.html</loc>
<image:image>
<image:title>Ghid preclinic de dozare: volumul IV și PO, PH și osmolaritate pentru PK precise la NHP și alte specii</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-copd-model-17499188998710272.html</loc>
<image:image>
<image:title>Modele de cercetare BPOC de top și excelență în platformă respiratorie de către prisuri</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499189018928128.html</loc>
<image:image>
<image:title>Model de hemoragie acută NHP: un instrument crucial pentru accelerarea dezvoltării de medicamente pentru hematologie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499189190091776.html</loc>
<image:image>
<image:title>Pruritus Research: Modelul NHP indus de IL-31 de Prisys Biotech pentru evaluarea terapiilor anti-Iit</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451761597965312.html</loc>
<image:image>
<image:title>Un ghid pentru evaluarea-anticorpilor antidrog (ADA).</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451761650213888.html</loc>
<image:image>
<image:title>Terapii respiratorii: Platforma NHP integrată a Prisys Biotech pentru cercetări preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451762326594560.html</loc>
<image:image>
<image:title>Modele de durere NHP: accelerarea dezvoltării medicamentelor analgezice la Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451761421706240.html</loc>
<image:image>
<image:title>Platforme model NHP pentru a sprijini dezvoltarea medicamentelor în boli complexe</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451761683588096.html</loc>
<image:image>
<image:title>Considerații cheie pentru dozarea volumului, PH-ului și formulării la modelele animale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451762114405376.html</loc>
<image:image>
<image:title>Exozomi proiectați: revoluționând livrarea de medicamente pentru tulburările SNC - Perspective preclinice de la Prisys Biotech</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451761519944704.html</loc>
<image:image>
<image:title>Principii directoare pentru selecția speciilor de animale în studiile de toxicologie a medicamentelor cu acid nucleic</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451761829372928.html</loc>
<image:image>
<image:title>DSA și IMRI de la Prisys Biotech pentru studii hematologice, vasculare și de boli renale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451761379304448.html</loc>
<image:image>
<image:title>Modele de durere de maimuță Cynomolgus: stimulează cercetarea translațională pentru terapie inovatoare cu canale ionice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451761432323072.html</loc>
<image:image>
<image:title>Avansarea cercetării dermatitei atopice: Modelul Prisys Biotech Non-Human Primate (NHP)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451761405256704.html</loc>
<image:image>
<image:title>Modelul de dermatită atopică NHP Prisys Biotech pentru dezvoltarea medicamentelor anti-pruritice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374229536072704.html</loc>
<image:image>
<image:title>Proiectarea studiilor pe animale: considerente cheie pentru succesul cercetării preclinice</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374229004772352.html</loc>
<image:image>
<image:title>Dermatită atopică: modul în care modelele de maimuță de cynomolgus avansează terapeutica de precizie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374228966630400.html</loc>
<image:image>
<image:title>Cercetarea astmului: de ce modelele de primate non--umane sunt esențiale pentru dezvoltarea de noi medicamente</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374228944102400.html</loc>
<image:image>
<image:title>Înțelegerea farmacocineticii oligonucleotidelor antisens (ASO): factori cheie în absorbție și distribuție</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374229340283904.html</loc>
<image:image>
<image:title>Studii de inhalare NHP pentru produse biologice: Serviciile CRO preclinice specializate ale PRISYS</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374229131830272.html</loc>
<image:image>
<image:title>Studii avansate preclinice de inhalare: capacități tehnice și experiență la Prisys Biotech</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374229111596032.html</loc>
<image:image>
<image:title>Înțelegerea farmacocineticii (PK): parametri cheie și aplicații în dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374229319492608.html</loc>
<image:image>
<image:title>Injecție intracerebroventriculară (ICV): livrare de precizie a sistemului nervos central pentru cercetări preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374229036180480.html</loc>
<image:image>
<image:title>Injecție intracerebrală (ICM): țintire cu precizie pentru terapia SNC - Considerații preclinice</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374229170791424.html</loc>
<image:image>
<image:title>Injecție intratecală (IT): O cale de livrare directă a SNC pentru terapii avansate - Considerații preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374229072192512.html</loc>
<image:image>
<image:title>Avansarea cercetării bolii Parkinson cu modelul NHP</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374229533549568.html</loc>
<image:image>
<image:title>Studii preclinice PK/PD și modele NHP pentru dezvoltarea medicamentelor|Prisys Biotech</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/300.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299479124665344.html</loc>
<image:image>
<image:title>Dirijarea interleukinei-31 (IL-31): O nouă frontieră în dezvoltarea medicamentelor pentru bolile autoimune – Modele Prisys Biotech NHP pentru cercetarea preclinică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295638797607936.html</loc>
<image:image>
<image:title>Evaluarea imunotoxicității nonclinice: strategie, considerații cheie și selecție a metodei</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/232.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295638693389312.html</loc>
<image:image>
<image:title>Testarea microbiană și impactul acesteia asupra primatelor non-umane în studiile preclinice DMPK</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295638794249216.html</loc>
<image:image>
<image:title>Model de endometrioză a maimuței Cynomolgus pentru avansarea cercetării terapeutice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/membranous-nephropathy-model-17295638602736640.html</loc>
<image:image>
<image:title>Dezvoltarea de medicamente pentru nefropatia membranoasă (MN) în avans: Platforma model de maimuță Cynomolgus de la Prisys Biotech</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295638854935552.html</loc>
<image:image>
<image:title>Farmacocinetica medicamentelor inhalate: o schimbare de paradigmă de la expunerea sistemică la expunerea pulmonară</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-for-womens-health-17295638561612800.html</loc>
<image:image>
<image:title>Prisys Biotech: Modele animale pentru terapie pentru sănătatea femeilor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295638863258624.html</loc>
<image:image>
<image:title>Ziua Obezității Mondiale|Modele metabolice Prisys Biotech NHP: Alimentarea dezvoltării terapiilor anti-obezitate de generație viitoare</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295638727648256.html</loc>
<image:image>
<image:title>Prisys Biotech's Cynomolgus Monkey Psoriasis Model: avansarea evaluării farmacodinamicii preclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295638615434240.html</loc>
<image:image>
<image:title>Integrarea farmacocineticii și farmacodinamicii în dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888417126278144.html</loc>
<image:image>
<image:title>La-Webinar la cerere|The Precision Bridge: RMN-CED ghidat și modele translatable NHP pentru administrarea de medicamente SNC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295638773900288.html</loc>
<image:image>
<image:title>Ce validează cu adevărat Proof Of Concept (PoC) în dezvoltarea medicamentelor?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295638516786176.html</loc>
<image:image>
<image:title>Modele de animale|Provocări și aplicații în dezvoltarea modelului de durere</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295673847342080.html</loc>
<image:image>
<image:title>Cercetări farmacodinamice nonclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244178601763840.html</loc>
<image:image>
<image:title>Selectarea primatului ideal non-uman pentru studiile de toxicologie: Macacul Cynomolgus, Macacul Rhesus și Marmoset</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120537.html</loc>
<image:image>
<image:title>Terapie țintită pentru boala Parkinson: revoluție în-RMN-în timp real transplantul de celule stem ghidat</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295638471959552.html</loc>
<image:image>
<image:title>Lupusul eritematos sistemic (LES) și rolul modelelor animale în dezvoltarea terapeutică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295638661374976.html</loc>
<image:image>
<image:title>Model de primat non-uman pentru artrita reumatoidă (RA)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295638584009728.html</loc>
<image:image>
<image:title>Instrumente stereotactice pentru creierul animalelor bazate pe sisteme de coordonate 3D</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295638952649728.html</loc>
<image:image>
<image:title>Modele de animale pentru testarea in vivo (1): stabilire și clasificare</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84001398.html</loc>
<image:image>
<image:title>Explorarea căilor potențiale pentru ca substanțele biologice să intre în creier</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84002184.html</loc>
<image:image>
<image:title>Avansarea cercetării artritei reumatoide (RA) cu modele de primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84001403.html</loc>
<image:image>
<image:title>Explorarea modelelor animale pentru eficacitatea medicamentului pentru dermatita atopică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84002185.html</loc>
<image:image>
<image:title>Rolul critic al modelelor animale în cercetarea bolilor umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84001399.html</loc>
<image:image>
<image:title>Modelul de maimuță cu deficiență a genei Parkin dezvăluie noi mecanisme și ținte terapeutice pentru boala Parkinson</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84001401.html</loc>
<image:image>
<image:title>Ghid de dezvoltare a medicamentelor nonclinice: studii de toxicitate generală acută, subacută, subcronică și cronică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84001413.html</loc>
<image:image>
<image:title>Livrarea inovatoare de medicamente de la naz la creier (N2B): ocolirea barierei hemato-encefalice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84001400.html</loc>
<image:image>
<image:title>Oportunități și provocări ale porcilor mini ca specie de animale mari nonclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83051925.html</loc>
<image:image>
<image:title>Strategii de livrare a medicamentelor pentru bolile creierului</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83055108.html</loc>
<image:image>
<image:title>Navigare RMN intraoperatorie-în timp real: Sprijinirea aprobării FDA a primei terapii genetice pentru deficiența AADC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83050843.html</loc>
<image:image>
<image:title>Studii de toxicitate oculară ale picăturilor pentru ochi: expunerea la medicamente și evaluarea siguranței</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82804131.html</loc>
<image:image>
<image:title>Prisys Biotech stabilește modelul de psoriazis al maimuței Cynomolgus pentru a accelera dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82804128.html</loc>
<image:image>
<image:title>Modele cuprinzătoare de primate non-umane pentru cercetarea bolilor renale de către Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82804126.html</loc>
<image:image>
<image:title>Evaluarea preclinică cuprinzătoare a siguranței conjugate de anticorpi-medicament (ADC) la primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82804125.html</loc>
<image:image>
<image:title>Evaluarea farmacocinetică a conjugaților de medicamente-anticorpi (ADC) la primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82804139.html</loc>
<image:image>
<image:title>Evaluarea farmacodinamică a ADC-urilor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82804124.html</loc>
<image:image>
<image:title>Înțelegerea DMPK a medicamentelor ADC</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82804130.html</loc>
<image:image>
<image:title>Progrese în dezvoltarea medicamentelor cu acizi nucleici și a capacităților de cercetare Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82351148.html</loc>
<image:image>
<image:title>Progrese în sistemele de livrare pulmonară ARNm și serviciile inovatoare ale Prisys biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82804136.html</loc>
<image:image>
<image:title>De ce a fost premiul Nobel pentru fiziologie sau medicină din 2024 acordat acestor doi oameni de știință care au studiat microARN?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82805388.html</loc>
<image:image>
<image:title>Considerații farmacocinetice (PK) pentru medicamentele pentru sistemul nervos central (SNC).</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656477.html</loc>
<image:image>
<image:title>Progrese în cercetarea SNC: Sistemul de injecție în creier compatibil cu RMN-Prisys Biotech și tehnologia CED</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120542.html</loc>
<image:image>
<image:title>Avansarea inovațiilor terapeutice privind sângerarea și coagularea cu modelul MCAO Cynomolgus Monkey</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120538.html</loc>
<image:image>
<image:title>Evaluarea DMPK a medicamentelor pentru sistemul nervos central (SNC).</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/animal-models-of-human-diseases-81120535.html</loc>
<image:image>
<image:title>Modele animale ale bolilor umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120532.html</loc>
<image:image>
<image:title>Inovații în evaluarea durerii: analiză comportamentală condusă de AI-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/china-experimental-monkey-industry-81120534.html</loc>
<image:image>
<image:title>Istoria, starea actuală, provocările și oportunitățile industriei experimentale a maimuțelor din China</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/human-disease-animal-models-81120536.html</loc>
<image:image>
<image:title>Modele animale cu boli umane: un instrument crucial pentru promovarea cercetării biomedicale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120540.html</loc>
<image:image>
<image:title>Importanța farmacodinamicii preclinice în dezvoltarea medicamentelor|Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120541.html</loc>
<image:image>
<image:title>Administrarea intranazală în studiile pe animale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410663.html</loc>
<image:image>
<image:title>Revoluționează dezvoltarea medicamentelor SNC: PRISYS Biotech introduce tehnologia IMRI</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/convection-enhanced-delivery-81120531.html</loc>
<image:image>
<image:title>Avansarea medicinei de precizie: tehnologia de convecție-Livrare îmbunătățită (CED) de la Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120533.html</loc>
<image:image>
<image:title>Cynomolgus Monkey Boala cronică de rinichi (CKD) Model de Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79527440.html</loc>
<image:image>
<image:title>Evaluarea nonclinică a siguranței administrării oculare de medicamente utilizând macaci Cynomolgus</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/compartment-pk-model-81120927.html</loc>
<image:image>
<image:title>Înțelegerea modelelor de compartiment și non{0}}compartimentare în farmacocinetică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120530.html</loc>
<image:image>
<image:title>Tehnici avansate de eliberare a SNC la maimuțele Cynomolgus: accelerarea dezvoltării medicamentelor cu oligonucleotide</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79527442.html</loc>
<image:image>
<image:title>Reducerea utilizării primatelor non-umane în evaluările nonclinice de siguranță: perspective de la FDA și industrie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79528311.html</loc>
<image:image>
<image:title>Bioanaliza preclinica LCMS a medicamentelor pentru terapie genetică bazate pe LNP-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mrna-based-therapies-past-79527461.html</loc>
<image:image>
<image:title>Terapii bazate{0}}MRNA: trecut</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pk-strategies-of-pdc-79528312.html</loc>
<image:image>
<image:title>Strategii de studiu farmacocinetic ale conjugatelor cu peptide-drog (PDC)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79528314.html</loc>
<image:image>
<image:title>Rolul AAV în terapia genică: răspunsuri imune și toxicitate</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79528316.html</loc>
<image:image>
<image:title>Strategii optimizate de evaluare a imunogenității nonclinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527480.html</loc>
<image:image>
<image:title>Evaluarea farmacodinamică (PD) a terapiei genice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527464.html</loc>
<image:image>
<image:title>Farmacocinetica și bioanaliza medicamentelor cu oligonucleotide-(1)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527463.html</loc>
<image:image>
<image:title>Farmacocinetica și bioanaliza medicamentelor cu oligonucleotide: caracteristici de absorbție și farmacocinetică plasmatică (PK)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527479.html</loc>
<image:image>
<image:title>Factori de luat în considerare pentru imunogenitatea medicamentelor cu oligonucleotide</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79528317.html</loc>
<image:image>
<image:title>MRNA: un instrument puternic și versatil pentru combaterea bolilor-Prisys-Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527454.html</loc>
<image:image>
<image:title>Oamenii de știință chinezi oferă noi strategii pentru a inversa simptomele de bază ale bolii Parkinson</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79527457.html</loc>
<image:image>
<image:title>Biotehnologie Prisys: Nanoparticule lipidice noi pentru livrarea MRNA la primate</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79527477.html</loc>
<image:image>
<image:title>Importanța cercetării în medicină translațională de la cercetarea de bază la studiile clinice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527453.html</loc>
<image:image>
<image:title>Principalii factori luați în considerare în analiza WOE</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79527478.html</loc>
<image:image>
<image:title>Cum să livrezi substanțe biologice în creier?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79527452.html</loc>
<image:image>
<image:title>Cum se mișcă și se schimbă medicamentele în corpurile noastre: o scurtă introducere în farmacocinetică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527462.html</loc>
<image:image>
<image:title>Cum să dezvoltați noi medicamente mai rapid și mai sigur: un ghid pentru studiile preclinice DMPK</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527473.html</loc>
<image:image>
<image:title>Ghid de cazare în grup pentru maimuțele de laborator</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527470.html</loc>
<image:image>
<image:title>Rolul vital al maimuțelor experimentale în avansarea cercetării științifice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527472.html</loc>
<image:image>
<image:title>Înțelegerea Macaca Fascicularis (maimuță Cynomolgus): caracteristici cheie și contribuții la cercetarea biomedicală</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79527467.html</loc>
<image:image>
<image:title>Revoluționarea tratamentului bolilor metabolice: progrese și provocări în dezvoltarea medicamentelor cu peptide</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79527443.html</loc>
<image:image>
<image:title>Cum se evaluează siguranța produselor pentru piele înainte de studiile clinice?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527458.html</loc>
<image:image>
<image:title>Rolul semnificativ al maimuțelor experimentale în dezvoltarea inovatoare a medicamentelor: o privire interioară asupra afacerii</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79528313.html</loc>
<image:image>
<image:title>Toxicitatea hepatică ca o preocupare cheie pentru medicamentele SiRNA: o analiză cuprinzătoare Specificitatea țintei: Sabia cu două-tăisuri a SiRNA</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79527446.html</loc>
<image:image>
<image:title>Avansarea SiRNA Therapeutics: Depășirea provocărilor în dezvoltarea medicamentelor</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79527449.html</loc>
<image:image>
<image:title>Perspectivele de aplicare ale medicamentelor genetice bazate pe nanoparticule lipidice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527451.html</loc>
<image:image>
<image:title>Puncte cheie în proiectarea strategiilor pentru studii non-clinice asupra animalelor juvenile</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79527460.html</loc>
<image:image>
<image:title>Perspectivă asupra trăsăturilor senzoriale și comportamentale ale primatelor non--umane (NHP)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527459.html</loc>
<image:image>
<image:title>Întrebări și răspunsuri privind evaluarea studiului nonclinic</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/significance-principles-and-requirements-of-79527481.html</loc>
<image:image>
<image:title>Semnificația, principiile și cerințele cercetării farmacologice de siguranță</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527456.html</loc>
<image:image>
<image:title>Cum se evaluează eficacitatea farmacologică preclitică?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527445.html</loc>
<image:image>
<image:title>Reflecții asupra studiilor non-clinice de farmacologie și a evaluării medicamentelor terapeutice pentru steatohepatita non{-alcoolică (NASH)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79527448.html</loc>
<image:image>
<image:title>Avansarea cercetării CNS și CGT: Prisys Biotechnologies</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79527444.html</loc>
<image:image>
<image:title>Orientări privind colectarea fluidului cefalorahidian pentru primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79527455.html</loc>
<image:image>
<image:title>Considerații pentru interpretarea datelor de patologie clinică la primate non--umane (NHP) și canini</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79527436.html</loc>
<image:image>
<image:title>​​​​​​​Integrarea evaluării siguranței SNC în studiile generale de toxicologie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79527447.html</loc>
<image:image>
<image:title>Cum se efectuează evaluarea preclinică de farmacologie/toxicologie a ADC-urilor?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527450.html</loc>
<image:image>
<image:title>Perspective ADME pentru medicamentele cu oligonucleotide (1) - Absorbție, distribuție</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79527469.html</loc>
<image:image>
<image:title>Perspective ADME pentru medicamentele cu oligonucleotide (2) - Metabolism și excreție</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79527439.html</loc>
<image:image>
<image:title>Studii preclinice pe animale (1) - Specii de animale</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79527437.html</loc>
<image:image>
<image:title>Provocări și strategii de interpretare a datelor de patologie clinică în studiile preclinice ale caninilor și primatelor non-umane{0}</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527471.html</loc>
<image:image>
<image:title>Studii preclinice pe animale (2) - Căi și volume de administrare</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mrna-based-therapies-present-79527475.html</loc>
<image:image>
<image:title>Terapii bazate pe -MRNA: prezente</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527474.html</loc>
<image:image>
<image:title>Terapii bazate pe MRNA-: viitor și provocări</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527468.html</loc>
<image:image>
<image:title>Scurtă introducere despre analiza biologică a terapiei genice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410661.html</loc>
<image:image>
<image:title>Maimuța Cynomolgus în cercetarea medicamentelor oftalmice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410664.html</loc>
<image:image>
<image:title>Studii translaționale și încrucișate-reactive cu modelele NHP de la Prisys de imunologie și inflamație</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79186645.html</loc>
<image:image>
<image:title>NHP ne-naivi în studiile preclinice: o soluție cost-eficientă de la Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-asthma-model-79186644.html</loc>
<image:image>
<image:title>Modelul de astm NHP: abilitarea studiilor preclinice de eficacitate a medicamentelor cu Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79186646.html</loc>
<image:image>
<image:title>Avansarea imunologiei și a cercetării asupra inflamației cu modele Cynomolgus Macaques - Prisys Biotechnologies</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79186643.html</loc>
<image:image>
<image:title>Livrarea directă a medicamentelor cu oligonucleotide în SNC și modificări histopatologice comune</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79186641.html</loc>
<image:image>
<image:title>Modelul intra-de accident vascular cerebral cerebral (ICH) al Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75160609.html</loc>
<image:image>
<image:title>Cercetarea farmacodinamică non-clinică: un aspect esențial în dezvoltarea medicamentelor SiRNA</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77696620.html</loc>
<image:image>
<image:title>Sistemul de localizare și livrare cu precizie a sistemului nervos central pentru animale mari, ghidat prin RMN-, se instalează în Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77051970.html</loc>
<image:image>
<image:title>Soluții inovatoare pentru promovarea terapiei respiratorii</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782795.html</loc>
<image:image>
<image:title>Prisys: Avansarea experimentării animalelor prin studiile Cynomolgus Macaque</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173433.html</loc>
<image:image>
<image:title>Prisys obține acreditarea completă de la AAALAC International: O etapă de hotar în asigurarea unor standarde înalte de îngrijire a animalelor de laborator.</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654558.html</loc>
<image:image>
<image:title>Creșterea terapiei cu acid nucleic prin{0}}de vârf cu modelele de primate non-umane Prisys Biotech</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74286032.html</loc>
<image:image>
<image:title>Revoluționarea livrării de medicamente pentru SNC: Prisys și promisiunea injectării intratecale</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75160610.html</loc>
<image:image>
<image:title>Prisys Biotech 2024 Q1 Newsletter - specialistul dvs. de încredere în studii non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73525615.html</loc>
<image:image>
<image:title>Cum-biopsia hepatică ghidată cu ultrasunete îmbunătățește cercetarea bazată pe macac-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73525616.html</loc>
<image:image>
<image:title>Orientări pentru utilizarea pe tot parcursul vieții a primatelor non-umane în cercetarea biomedicală: o perspectivă a biotehnologiei Prisys</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001106.html</loc>
<image:image>
<image:title>Primatele non-umane: o scurtă introducere în caracteristicile lor biologice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72673820.html</loc>
<image:image>
<image:title>Recenzia expoziției|Prisys Biotech strălucește la reuniunea anuală a Societății Americane pentru Neuroscience (SfN 2023)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321102.html</loc>
<image:image>
<image:title>Faceți cunoștință cu Prisys Biotech la reuniunea anuală a Societății pentru Neuroscience (SfN 2023)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321103.html</loc>
<image:image>
<image:title>Ziua Mondială a AVC|Concentrați-vă pe modele animale și farmacologie pentru accident vascular cerebral ischemic</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321100.html</loc>
<image:image>
<image:title>Prisys Biotech vă invită să participați la întâlnirea anuală SAPA-China în 2023</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321104.html</loc>
<image:image>
<image:title>Ziua Mondială a Alzheimer|Provocările și soluțiile pentru dezvoltarea medicamentelor AD</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321101.html</loc>
<image:image>
<image:title>Modelul animal Cynomolgus Macaque de la Prisys Biotech ajută la dezvoltarea de noi medicamente anticoagulante</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70945983.html</loc>
<image:image>
<image:title>Prisys: Furnizarea unui serviciu de experimente animale de înaltă calitate pentru noul anticorp BJTJ-1837 pentru factorul XI de coagulare anti-</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70945977.html</loc>
<image:image>
<image:title>Metodă pentru stabilirea unui model de maimuță Cynomolgus al hipertrigliceridemiei și aplicarea acestuia</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70950234.html</loc>
<image:image>
<image:title>Farmacologie: parametrii principali și semnificația farmacocineticii (PK)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70945976.html</loc>
<image:image>
<image:title>Evaluarea farmacologică preclinică a medicamentelor cu virus oncolitic</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/0-70945982.html</loc>
<image:image>
<image:title>Cum medicamentele mici cu acizi nucleici pot transforma tratamentul bolilor SNC: perspective de la Prisys Biotechnology, un furnizor de modele de boli NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70945986.html</loc>
<image:image>
<image:title>Farmacocinetică, strategii de cercetare și studii de caz ale medicamentelor cu peptide</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69658196.html</loc>
<image:image>
<image:title>Puncte cheie de cercetare ale ADC Drug PK</image:title>
<image:loc>https://img01.v15cdn.com/gallery/4x3/148.webp</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69656793.html</loc>
<image:image>
<image:title>Prisys Biotechnology: Un lider în platforma de cercetare pentru modelarea bolilor NHP CNS</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309360.html</loc>
<image:image>
<image:title>Cum să slăbești și să controlezi diabetul cu produse GLP-1</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309316.html</loc>
<image:image>
<image:title>Cum ajută China Maimuța să efectueze eficiența cercetării preclinice?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309263.html</loc>
<image:image>
<image:title>Care este eficiența ARNi?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309264.html</loc>
<image:image>
<image:title>Platforma de serviciu public Prisys Biotech pentru experimente cu animale mari: soluție cu costuri reduse-și eficiență- ridicată pentru experimentele cu animale mari</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69148005.html</loc>
<image:image>
<image:title>Cum îți poate salva terapia genică AAV</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69148001.html</loc>
<image:image>
<image:title>Prisys Biotech prezintă o platformă model de primate non-umane la reuniunea anuală a Societății Japoneze de Toxicologie</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69148003.html</loc>
<image:image>
<image:title>Viitorul promițător al terapiei genice AAV la primatele non--umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69148002.html</loc>
<image:image>
<image:title>Ce sunt nanoparticulele lipidice pentru terapia genică?</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69148007.html</loc>
<image:image>
<image:title>Prisys Biotech vă invită să participați la cea de-a 50-a întâlnire anuală a Societății Japoneze de Toxicologie (JSOT)</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69148588.html</loc>
<image:image>
<image:title>Test de imunotoxicitate, evaluarea siguranței medicamentelor-PRISYS BIOTECH</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68311497.html</loc>
<image:image>
<image:title>Un model animal optim de accident vascular cerebral ischemic stabilit prin angiografie digitală cu scădere{0}}Trombi autologi ghidați la maimuțele Cynomolgus</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68107632.html</loc>
<image:image>
<image:title>De ce ar trebui să vă pese de primatele non-umane din sistemul de eliberare a medicamentelor cu acid nucleic Cercetare și dezvoltare</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68107634.html</loc>
<image:image>
<image:title>Faceți cunoștință cu Prisys Biotech la 70th JALAS 2023!</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68107638.html</loc>
<image:image>
<image:title>Terapia genetică strălucește cu noi aprobări pentru boli rare</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68107639.html</loc>
<image:image>
<image:title>Revoluționează descoperirea medicamentelor: modul în care primatele non-umane optimizează screeningul SiRNA pentru rezultate mai rapide și mai eficiente</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67237923.html</loc>
<image:image>
<image:title>Maximizarea eficienței farmacologiei SiRNA cu cercetarea primatelor non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67237922.html</loc>
<image:image>
<image:title>Cum primatele non-umane pot revoluționa cercetarea SiRNA: un ghid cuprinzător</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67237921.html</loc>
<image:image>
<image:title>Sărbătorirea Zilei Mondiale a Animalelor de Laborator: De ce Prisys se angajează să promoveze sănătatea primatelor non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67237919.html</loc>
<image:image>
<image:title>Maximizarea eficienței cercetării CRISPR/Cas9 cu modele de primate non-umane</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67237917.html</loc>
<image:image>
<image:title>Dezlănțuirea potențialului terapeutic: de ce investiția în medicamente cu acizi nucleici este viitorul medicinei</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67237918.html</loc>
<image:image>
<image:title>Deblocarea potențialului primatelor non-umane în îmbunătățirea descoperirii țintei medicamentului în terapia genică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/world-parkinsons-disease-day-67237916.html</loc>
<image:image>
<image:title>Uniți pentru boala Parkinson: Împărtășiți-vă pentru a crește gradul de conștientizare cu privire la Ziua Mondială a Bolii Parkinson</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67237920.html</loc>
<image:image>
<image:title>Cum să utilizați în mod eficient primatele non-umane în evaluarea siguranței terapiei genice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/gene-therapy-toxicology-66266569.html</loc>
<image:image>
<image:title>Cercetarea toxicologiei terapiei genice cu primate Nonhuam</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085897.html</loc>
<image:image>
<image:title>Un ghid cuprinzător pentru realizarea unui studiu DMPK pentru terapia genică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/gene-therapy-nhp-model-66085888.html</loc>
<image:image>
<image:title>Revoluționarea cercetării medicale: descoperiri ale terapiei genice în modelele de boli de primate non-umane!</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085892.html</loc>
<image:image>
<image:title>Top 10 întrebări populare legate de terapia genică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085889.html</loc>
<image:image>
<image:title>Prisys Biotech: Farmacologie non-primatelor umane pentru terapia genică</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085891.html</loc>
<image:image>
<image:title>Sprijinirea sănătății femeilor: o privire asupra endometriozei</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-sot2023-66085885.html</loc>
<image:image>
<image:title>PRISYS și Taichu Group colaborează pentru expoziția SOT din 2023</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085887.html</loc>
<image:image>
<image:title>Avem nevoie de studii suplimentare pentru evaluarea durerii? - NHP</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085886.html</loc>
<image:image>
<image:title>Alăturați-vă nouă pentru a sărbători Ziua Mondială a Faunei Sălbatice</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085884.html</loc>
<image:image>
<image:title>Prisys Shanghai NHP R&amp;D Center se lansează, marcând o etapă în cercetarea și dezvoltarea farmaceutică în China</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg</image:loc>
</image:image>
</url>
<url>
<loc>https://ro.prisysbiotech.com/news/meetprisys-sot2023-66085883.html</loc>
<image:image>
<image:title>Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow</image:title>
<image:loc>https://ro.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg</image:loc>
</image:image>
</url>
</urlset>